Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 17, 2008
Uncertainty and sensitivity analyses of a decision analytic model for posteradication polio risk managementRadboud J Duintjer Tebbens, Mark A Pallansch, Olen M Kew, et al.
The New England Journal of Medicine|June 25, 2010
Implications of a circulating vaccine-derived poliovirus in NigeriaHelen E Jenkins, R Bruce Aylward, Alex Gasasira, et al.
The New England Journal of Medicine|February 1, 2013
Priming after a fractional dose of inactivated poliovirus vaccineSonia Resik, Alina Tejeda, Roland W Sutter, et al.
American Journal of Public Health|May 31, 2008
The risks, costs, and benefits of possible future global policies for managing poliovirusesKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Lancet (London, England)|October 29, 2010
Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trialRoland W Sutter, T Jacob John, Hemant Jain, et al.
Neurology|April 1, 2014
Dorsal root ganglionopathy is responsible for the sensory impairment in CANVASDavid J Szmulewicz, Catriona A McLean, Michael L Rodriguez, et al.
Nutrition Reviews|September 19, 2019
Omega-3 polyunsaturated fatty acid oral supplements for improving peripheral nerve health: a systematic review and meta-analysisAlexis Ceecee Zhang, Manikkuwadura Eranda Harshan De Silva, Richard J MacIsaac, et al.
The Lancet. Infectious Diseases|November 11, 2011
Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trialConcepción F Estívariz, Hamid Jafari, Roland W Sutter, et al.
National Science Review|April 11, 2022
Detecting subtle yet fast skeletal muscle contractions with ultrasoft and durable graphene-based cellular materialsZijun He, Zheng Qi, Huichao Liu, et al.
Lancet (London, England)|September 22, 2015
Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trialRoland W Sutter, Sunil Bahl, Jagadish M Deshpande, et al.
Pageof 8